A selective, rapid and sensitive reverse phase ultra- performance
liquid chromatography method was developed for the quantitative
determination of fexofenadine in human plasma. With carbamazepine
as internal standard, sample pretreatment involved a one-step
extraction with ethyl acetate from 980 l plasma. The sample was
analyzed using 10mM KH2PO4 buffer pH 2.5 and acetonitrile (70:30
v/v) as mobile phase. Chromatographic separation was achieved on an
ACQUITY UPLC BEH (C-18) column using isocratic elution. The peak
was detected using UV-PDA detector set at 210 nm and the total time
for chromatographic separation was 10 min. Linear calibration
curves were obtained in the concentration range of 30.09-1805.39
ng/ml with a lower limit of quantification of 30.09 ng/ml. The
inter and intra- day precision (RSD) values were below 15% and
accuracy (RE) was from 1.55 to 5.51 % at all QC levels. Developed
method was found to be accurate, precise, selective and rapid for
estimation of fexofenadine in plasma and can be used for
pharmacokinetic and bioequivalence studies.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!